Cardiovascular Healthcare in the UAE
Open Access
- 2 November 2025
- book chapter
- Published by Springer Nature
- p. 313-333
Abstract
Cardiovascular disease and its associated risk factors impose a huge morbidity, mortality, and disability burden on the UAE population, to an extent exceeding the global rates. In the last two decades, the UAE cardiovascular healthcare sector has undergone massive development, with the establishment of highly specialized centers, partnerships with world-renowned health institutions, high-quality clinical cardiovascular research, and the initiation of cardiovascular training programs. However, further efforts are warranted to increase public awareness of the burden of cardiovascular disease, promote healthy behaviors, tackle cardiovascular risk factors, and improve adherence to recent guidelines in order to improve patient outcomes. Here, we present epidemiological data on cardiovascular disease in the UAE, a historical perspective, major milestones in the care of cardiac patients, and current challenges and future directions in the field.Keywords
Funding Information
- Emirates Oncology Society
This publication has 56 references indexed in Scilit:
- Advanced heart failure therapies in the Eastern Mediterranean Region: current status, challenges, and future directionsCurrent Problems in Cardiology, 2024
- Survival To Discharge Among Cardiogenic Shock Patients Supported By VA-ECMO: An Insight From The Largest VA-ECMO Experience In The Middle East-Gulf RegionJournal of Cardiac Failure, 2024
- The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to KnowCurrent Atherosclerosis Reports, 2023
- Screening And Prevalence Of Iron Deficiency In An Outpatient Heart Failure Clinic In The Middle East Gulf RegionJournal of Cardiac Failure, 2023
- Outcomes of Myocardial Revascularization in Diabetic Patients With Left Main Coronary Artery Disease: A Multicenter Observational Study From Three Gulf CountriesCardiovascular Revascularization Medicine, 2022
- Patient Characteristics Of Heart Failure With Improved Ejection Fraction (HFimpEF) Following Treatment With Sacubitril/Valsartan: A Real-world Experience From The Middle EastJournal of Cardiac Failure, 2022
- Population awareness of cardiovascular disease risk factors and health care seeking behavior in the UAEAmerican Journal of Preventive Cardiology, 2021
- Establishing the first pharmacist‐led heart failure medication optimization clinic in the Middle East Gulf RegionJACCP: Journal of the American College of Clinical Pharmacy, 2020
- Beyond Borders: Our Middle Eastern Experience of International Collaboration to Run a Successful Heart Transplantation ProgramJournal of Cardiac Failure, 2018
- Hospitalized Heart Failure Patients with Preserved vs. Reduced Ejection Fraction in Dubai, United Arab Emirates: A Prospective StudyEuropean Journal of Heart Failure, 2014